Kenji Murata

1.1k citations
49 papers · 764 indexed · h-index 14
Topics
Immunotherapy and Immune Responses (20 papers)Cancer Immunotherapy and Biomarkers (16 papers)CAR-T cell therapy research (14 papers)
Partner nations
JapanCanadaSweden

In The Last Decade

Kenji Murata

45 papers receiving 749 citations

Peers

Kenji Murata
Comparison fields: 5 of 91
  • Oncology 334
  • Molecular Biology 282
  • Immunology 225
  • Genetics 128
  • Pulmonary and Respiratory Medicine 74
Replace Leslee Sprague with:
Leslee Sprague United States
Sashko Damjanovski Canada
Takashi Hasebe Japan
Axel M. Küchler Norway
Julia A. Horsfield New Zealand
J. Denry Sato United States
Kenta Fujimoto Japan
María L. Varela Argentina
Peter K. Nicholls Australia
Anthony E. Woods Australia
Kenji Murata relative to Leslee Sprague United States Leslee Sprague's profile →
Citations per field
00.5×6.7×
Leslee Sprague · 1×
Citations per year

Countries citing papers authored by Kenji Murata

Since Specialization
Citations

This map shows the geographic impact of Kenji Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Murata more than expected).

Fields of papers citing papers by Kenji Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Murata. The network helps show where Kenji Murata may publish in the future.

Co-authorship network of co-authors of Kenji Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Murata. A scholar is included among the top collaborators of Kenji Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Murata. Kenji Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 2
5 1
6 2
7 1
8 5
9 7
10 7
11 2
12 9
13 6
14 9
15 14
16 24
17 126
18 4
19 38
20 7

About Kenji Murata

Kenji Murata is a scholar working on Immunology, Oncology and Archeology, having authored 49 papers that have together received 764 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), Cancer Immunotherapy and Biomarkers (16 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Oncology (334 citations), Physiology (55 citations) and Immunology (225 citations). Kenji Murata has collaborated with scholars based in Japan, Canada and Sweden. Frequent co-authors include Kiyoshi Naruse, Masato Kinoshita, Minoru Tanaka, Toshihiko Torigoe, Tomohide Tsukahara, Terufumi Kubo, Yoshihiko Hirohashi, Takayuki Kanaseki, Toshihiko Yamashita and Naoto Hirano. Their work appears in journals such as Journal of Biological Chemistry, Nature Biotechnology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026